Steffan Heeger, MD, PhD

Chief Medical Officer


Dr. Steffen Heeger, MD, PhD, is Chief Medical Officer at Pega-One. Steffen has over fifteen years industry experience in the clinical development of targeted cancer therapies. Throughout his career, he led clinical development programs predominantly in the areas of hematological malignancies and in solid tumors.

Steffen is an internationally recognized leader with a strong track record in the clinical development of antibody-based, targeted oncology drugs. His work was instrumental for the development of the blockbuster drug ERBITUX®, a monoclonal therapeutic antibody targeting EGFR, and for successful clinical development of other anti-cancer therapeutic antibodies, e.g. targeting CD19, CD38 and PSMA.

Read more here about Pega-One

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser